Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand

Osnat Bohana-Kashtan, Sebastien Morisot, Richard Hildreth, Cory Brayton, Hyam I. Levitsky, Curt I. Civin

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand'. Together they form a unique fingerprint.

Medicine & Life Sciences